Immunotherapy of multiple sclerosis:: Where are we?: Where should we go?

被引：60
|
作者：
Martin, R
Stürzebecher, CS
McFarland, HF
机构：
[1] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
[2] Schering AG, Clin Dev CNS, D-13342 Berlin, Germany
来源：
NATURE IMMUNOLOGY | 2001年 / 2卷 / 09期
关键词：
D O I：
10.1038/ni0901-785
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Differences in multiple sclerosis patient's disease and their responses to standard drugs indicate that today's therapies need to be more individualized. It is proposed that gene expression profiling in conjunction with magnetic resonance imaging be used to optimize future treatment approaches.
引用
下载
收藏
页码：785 / 788
页数：4
相关论文
共 50 条
  • [21] Breast cancer research: where we are and where we should go
    Liu, ET
    BREAST CANCER RESEARCH, 2000, 2 (02) : 73 - 76
  • [22] Resveratrol supplementation: Where are we now and where should we go?
    Novelle, Marta G.
    Wahl, Devin
    Dieguez, Carlos
    Bernier, Michel
    de Cabo, Rafael
    AGEING RESEARCH REVIEWS, 2015, 21 : 1 - 15
  • [23] Philosophy and information systems: where are we and where should we go?
    Hassan, Nik Rushdi
    Mingers, John
    Stahl, Bernd
    EUROPEAN JOURNAL OF INFORMATION SYSTEMS, 2018, 27 (03) : 263 - 277
  • [24] Community Deception in Networks: Where We Are and Where We Should Go
    Fionda, Valeria
    Pirro, Giuseppe
    COMPLEX NETWORKS & THEIR APPLICATIONS X, VOL 2, 2022, 1016 : 144 - 155
  • [25] Breast cancer research: where we are and where we should go
    Edison T Liu
    Breast Cancer Research, 2
  • [26] The burden of blood pressure: Where are we and where should we go?
    Hamet, P
    CANADIAN JOURNAL OF CARDIOLOGY, 2000, 16 (12) : 1483 - 1487
  • [27] Uterine fibroid embolization: where are we and where should we go?
    Pelage, JP
    Fauconnier, A
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2005, 25 (06) : 527 - 534
  • [28] Cognitive and Psychosocial Issues in Pediatric Multiple Sclerosis: Where We Are and Where We Need To Go
    Amato, Maria Pia
    NEUROPEDIATRICS, 2012, 43 (04) : 174 - 175
  • [29] ISNT THIS WHERE WE SHOULD GO
    FLAHERTY, JA
    SMPTE JOURNAL, 1994, 103 (01): : 41 - 44
  • [30] Immunotherapy for esophageal cancer: Where are we now and where can we go
    Shoji, Yoshiaki
    Koyanagi, Kazuo
    Kanamori, Kohei
    Tajima, Kohei
    Ogimi, Mika
    Ninomiya, Yamato
    Yamamoto, Miho
    Kazuno, Akihito
    Nabeshima, Kazuhito
    Nishi, Takayuki
    Mori, Masaki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (19) : 2496 - 2501
12345